Table of Content

Table of Contents

1. Executive Summary

2. Global Trastuzumab Biosimilar Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031
3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
3.2. Global Trastuzumab Biosimilar Market Trends (2019-2024) and Forecast (2025-2031)
3.3: Global Trastuzumab Biosimilar Market by Product
3.3.1: Ogivri
3.3.2: Herzuma
3.3.3: Ontruzant
3.3.4: Trazimera
3.3.5: Others
3.4: Global Trastuzumab Biosimilar Market by Indication
3.4.1: Adjuvant Breast Cancer
3.4.2: Metastatic Breast Cancer
3.4.3: Metastatic Gastric Cancer
3.4.4: Others
3.5: Global Trastuzumab Biosimilar Market by Distribution Channel
3.5.1: Hospital Pharmacy
3.5.2: Online Pharmacy

4. Market Trends and Forecast Analysis by Region from 2019 to 2031
4.1: Global Trastuzumab Biosimilar Market by Region
4.2: North American Trastuzumab Biosimilar Market
4.2.1: North American Market by Product: Ogivri, Herzuma, Ontruzant, Trazimera, and Others
4.2.2: North American Market by Indication: Adjuvant Breast Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer, and Others
4.3: European Trastuzumab Biosimilar Market
4.3.1: European Market by Product: Ogivri, Herzuma, Ontruzant, Trazimera, and Others
4.3.2: European Market by Indication: Adjuvant Breast Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer, and Others
4.4: APAC Trastuzumab Biosimilar Market
4.4.1: APAC Market by Product: Ogivri, Herzuma, Ontruzant, Trazimera, and Others
4.4.2: APAC Market by Indication: Adjuvant Breast Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer, and Others
4.5: ROW Trastuzumab Biosimilar Market
4.5.1: ROW Market by Product: Ogivri, Herzuma, Ontruzant, Trazimera, and Others
4.5.2: ROW Market by Indication: Adjuvant Breast Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer, and Others

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Trastuzumab Biosimilar Market by Product
6.1.2: Growth Opportunities for the Global Trastuzumab Biosimilar Market by Indication
6.1.3: Growth Opportunities for the Global Trastuzumab Biosimilar Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Trastuzumab Biosimilar Market by Region
6.2: Emerging Trends in the Global Trastuzumab Biosimilar Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Trastuzumab Biosimilar Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Trastuzumab Biosimilar Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: Pfizer
7.2: Outlook Therapeutics
7.3: Merck
7.4: Amgen
7.5: BioXpress Therapeutics
7.6: Teva Pharmaceutical Industries
7.7: Mylan
7.8: Fujifilm Kyowa Kirin Biologics
7.9: Innovent Biologics
7.10: STADA Arzneimittel